Stocks & Investing
Stocks and Investing
Stocks and Investing
Wed, March 30, 2022
[ Wed, Mar 30th 2022
] - WOPRAI
[ Wed, Mar 30th 2022
] - WOPRAI
[ Wed, Mar 30th 2022
] - WOPRAI
[ Wed, Mar 30th 2022
] - WOPRAI
[ Wed, Mar 30th 2022
] - WOPRAI
[ Wed, Mar 30th 2022
] - WOPRAI
[ Wed, Mar 30th 2022
] - WOPRAI
[ Wed, Mar 30th 2022
] - WOPRAI
[ Wed, Mar 30th 2022
] - WOPRAI
[ Wed, Mar 30th 2022
] - WOPRAI
[ Wed, Mar 30th 2022
] - WOPRAI
[ Wed, Mar 30th 2022
] - WOPRAI
[ Wed, Mar 30th 2022
] - WOPRAI
[ Wed, Mar 30th 2022
] - WOPRAI
[ Wed, Mar 30th 2022
] - WOPRAI
[ Wed, Mar 30th 2022
] - WOPRAI
[ Wed, Mar 30th 2022
] - WOPRAI
[ Wed, Mar 30th 2022
] - WOPRAI
[ Wed, Mar 30th 2022
] - WOPRAI
[ Wed, Mar 30th 2022
] - WOPRAI
[ Wed, Mar 30th 2022
] - WOPRAI
[ Wed, Mar 30th 2022
] - WOPRAI
[ Wed, Mar 30th 2022
] - WOPRAI
[ Wed, Mar 30th 2022
] - WOPRAI
[ Wed, Mar 30th 2022
] - WOPRAI
[ Wed, Mar 30th 2022
] - WOPRAI
[ Wed, Mar 30th 2022
] - WOPRAI
[ Wed, Mar 30th 2022
] - WOPRAI
[ Wed, Mar 30th 2022
] - WOPRAI
Jonathan Chang Maintained (VINC) at Buy with Decreased Target to $20 on, Mar 30th, 2022
Jonathan Chang of SVB Leerink, Maintained "Vincerx Pharma, Inc." (VINC) at Buy with Decreased Target from $24 to $20 on, Mar 30th, 2022.
Jonathan has made no other calls on VINC in the last 4 months.
There is 1 other peer that has a rating on VINC. Out of the 1 peers that are also analyzing VINC, 0 agree with Jonathan's Rating of Hold.
This is the rating of the analyst that currently disagrees with Jonathan
- Li Watsek of "Cantor Fitzgerald" Initiated at Buy and Held Target at $25 on, Thursday, December 23rd, 2021
